Elimination of CD4+CD25+ Regulatory T Cells in Patients With Advanced HCC After Treatment With Cyclophosphamide
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Frequency of CD4+CD25+regulatory T cells
within 8 weeks
Tim F Greten, M.D.
Department of Gastroenterology, Medizinische Hochschule Hannover
Germany: Federal Institute for Drugs and Medical Devices